Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET)

被引：0
|
作者：
Agostoni, Pierfrancesco [1 ]
Vermeersch, Paul [1 ]
Verheye, Stefan [1 ]
Van den Heuvel, Paul [1 ]
Carl, Convens [1 ]
Van den Branden, Frank [1 ]
Van Langenhove, Glenn [1 ]
机构：
[1] Antwerp Cardiovasc Inst, Middelheim, AZ Middelheim, B-2020 Antwerp, Belgium
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷 / 15期
关键词：
D O I：
10.1093/eurheartj/ehm205
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1912 / 1913
页数：2
相关论文
共 50 条
  • [1] Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)
    Brunner-La Rocca, Hans-Peter
    Kaiser, Christoph
    Pfisterer, Matthias
    EUROPEAN HEART JOURNAL, 2007, 28 (06) : 719 - 725
  • [2] Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET): Reply
    Pfisterer, Matthias
    Kaiser, Christoph
    Brunner-La-Rocca, Hanspeter
    EUROPEAN HEART JOURNAL, 2007, 28 (15) : 1913 - 1913
  • [3] Basel Stent cost-effectiveness trial (Basel Stent Kosten Effektivitats Trials; BASKET): trial design and comparison of baseline findings with those of the RESEARCH trial
    Kaiser, C.
    Bernheim, A.
    Zutter, A.
    Brunner-La-Rocca, H. P.
    Buser, P.
    Osswald, S.
    Linka, A.
    Pfisterer, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 708 - 708
  • [4] Basel stent cost-effectiveness trial-late thrombotic events trial
    Richartz, B
    Silber, S
    HERZ, 2006, 31 (03) : 259 - 259
  • [5] Drug-eluting coronary stents in clinical practice: lessons from the "BAsel Stent Kosten-Effektivitats Trials" (BASKET)
    Pfisterer, Matthias
    Nietlispach, Fabian
    Jeger, Raban
    Kaiser, Christoph
    SWISS MEDICAL WEEKLY, 2011, 141
  • [6] Die BASKET-LATE-StudieBasel Stent Cost-Effectiveness Trial-Late Thrombotic Events Trial
    Herz Kardiovaskuläre Erkrankungen, 2006, 31 : 259 - 259
  • [7] Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET)
    Kaiser, C
    Brunner-LaRocca, HP
    Buser, PT
    Bonetti, PO
    Osswald, S
    Linka, A
    Bernheim, A
    Zutter, A
    Zellweger, M
    Grize, L
    Pfisterer, ME
    LANCET, 2005, 366 (9489): : 921 - 929
  • [8] Cost and cost effectiveness at 1 year in the stent or surgery trial (SoS)
    Weintraub, W
    Mahoney, E
    Zhang, Z
    Booth, J
    Hutton, J
    Stables, R
    Nugara, F
    Buxton, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 137 - 137
  • [9] Do drug-eluting stents reduce in-hospital events compared to bare metal stents? First results of the prospective Basel stent cost-effectiveness trial (Basel Stent Kosten Effektivitaets Trial)
    Kaiser, C.
    Brunner-La Rocca, H. P.
    Zutter, A.
    Bernheim, A.
    Osswald, S.
    Buser, P.
    Linka, A.
    Pfisterer, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 313 - 313
  • [10] Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis
    Brunner-La Rocca, Hans Peter
    Kaiser, Christoph
    Bernheim, Alain
    Zellweger, Michael J.
    Jeger, Raban
    Buser, Peter T.
    Osswald, Stefan
    Pfisterer, Matthias
    LANCET, 2007, 370 (9598): : 1552 - 1559
12345